Loading insider details...
Beta
Latest Form 4 (Oct 7, 2026): Disposition to Issuer of 17,142 ABUS shares, $85.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | Arbutus Biopharma Corp (ABUS) | Disposition to Issuer | 17,142 | $85.7K |
| Sep 24, 2026 | Arbutus Biopharma Corp (ABUS) | Exercise/Conversion | 52,533 | $175.5K |
| Jun 10, 2026 | Arbutus Biopharma Corp (ABUS) | Grant/Award | 78,800 | n/a |
| May 22, 2026 | ACTUATE THERAPEUTICS, INC. (ACTU) | Grant/Award | 15,000 | n/a |
| Aug 6, 2025 | Arbutus Biopharma Corp (ABUS) | Grant/Award | 157,600 | n/a |
| May 23, 2025 | ACTUATE THERAPEUTICS, INC. (ACTU) | Grant/Award | 15,000 | n/a |
| Aug 14, 2024 | ACTUATE THERAPEUTICS, INC. (ACTU) | Grant/Award | 30,000 | n/a |